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Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)
is the most common form of hereditary cerebral small vessel disease. Previous neuroimaging studies
have suggested loss of hippocampal volume is a pathway for cognitive impairment in CADASIL. We used
unbiased stereological methods to estimate SMI32-positive and total numbers and volumes of neurons in
the hippocampal formation of 12 patients with CADASIL and similar age controls (young controls) and
older controls. We found densities of SMI32-positive neurons in the entorhinal cortex, layer V, and cornu
ammonis CA2 regions were reduced by 26%e50% in patients with CADASIL compared with young con-
trols (p < 0.01), with a decreasing trend observed in older controls in the order of young controls> older
controls  CADASIL. These changes were not explained by any hippocampal infarct or vascular pathology
or glial changes. Our results suggest notable loss of subsets of projection neurons within the hippo-
campal formation that may contribute to certain memory deficits in CADASIL, which is purely a vascular
disease. It is likely that the severe arteriopathy leads to white matter damage which disconnects cortico-
cortical and subcortical-cortical networks including the hippocampal formation.
 2020 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Loss of neurons and subsequent atrophy of the hippocampal
formation within the cornu ammonis (CA) fields, subiculum and
entorhinal cortex (EC), are common pathological changes observed
in different stages of cognitive impairment including mild cognitive
impairment (Pennanen et al., 2004), Alzheimer's disease (AD)
(Gomez-Isla et al., 1996; Kril et al., 2002a), and dementia with Lewy
body (Harding et al., 2002). In the EC, layer II appears to be the first
affected area, which is the origin of input signals to the hippo-
campal CA fields through the perforant path, whereas EC layer V
(ECV) receives major hippocampal output from the CA1 and returns
the signal to the neocortex and subcortical structures such as theal Research Institute, Faculty
Newcastle University, New-
ax: 0191 248 1301.
.
Inc. This is an open access articlethalamus. It is thought that layers II and V in the EC play critical
roles in memory processing (Knierim, 2015).
Previous studies including ours (Gemmell et al., 2012; Kril et al.,
2002b; Zarow et al., 2005) quantified densities of hippocampal
neurons in vascular dementia (VaD) with the overall findings of
decreases in numbers or volumes of CA1 and CA2 pyramidal neu-
rons (Kril et al., 2002b; Zarow et al., 2005). However, there were
contradictory findings in these studies that are likely explained by
the diverse underlying pathology and inconsistent definitions
associated with VaD (Kalaria, 2016; Kalaria et al., 2004).
Cerebral autosomal dominant arteriopathy with subcortical in-
farcts and leukoencephalopathy (CADASIL) is the most common
form of hereditary small vessel disease (SVD) caused by mutations
in the NOTCH3 gene (Chabriat et al., 2009). Patients with CADASIL
develop severe arteriopathy and subcortical ischemic infarcts,
which often lead to the manifestation of migraine with aura,
subcortical infarcts, mood disturbances, and eventually cognitive
impairment (Chabriat et al., 2009). The profile of cognitiveunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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manifests as impairments in processing speed and executive
function in contrast to that in AD, that is, word recall and recog-
nition memory but relatively preserved semantic fluency (Buffon
et al., 2006; Levy and Chelune, 2007). In the late stages, patients
with CADASIL develop variable degrees of vascular cognitive
impairment (VCI) (Hachinski et al., 2006; Skrobot et al., 2018).
However, the impact of the vascular pathology on neurons and thus
on cognitive function domains including memory in patients with
CADASIL remains to be fully determined.
To our knowledge, previous studies have not systematically
investigated neuronal density changes in patients with CADASIL.
Because of the genetically defined disease and younger age of onset,
alterations in CADASIL are of purely vascular origin and brains are
predominantly free of any Alzheimer type of pathology. However, a
single case described as a cortical form of CADASIL with cerebral
Abamyloidosis exhibited classical subcortical vascular pathology
with numerous lacunar infarcts (Paquet et al., 2010). Cerebral at-
rophy underlying cognitive dysfunction in CADASIL appears rela-
tively uniform although the anterior temporal poles are often
severely affected (Yamamoto et al., 2009) that may extend to other
regions of the temporal lobe. Consistent with this, previous
comprehensive neuroimaging studies in a large cohort indicated
that hippocampal volume was an independent predictor of cogni-
tive function in CADASIL (O'Sullivan et al., 2009). Hippocampal
volumes were reduced in patients with CADASIL who developed
dementia and in a subgroup progressing to dementia before age
60 years. On the basis that hippocampal atrophy is an important
pathway of cognitive impairment also in vascular disease (Kalaria
and Ihara, 2017), we reasoned that an examination of hippocam-
pal neurons and associated axonal changes in the temporal stem in
patients with CADASIL using specific markers such as SMI32
(Gottron et al., 1995; Lindner et al., 2009) may provide insights into
the neuronal substrates of cognitive impairment in VaD (Gemmell
et al., 2012). SMI32, which comprises nonphosphorylated
neurofilaments-M and -H, is found in pyramidal projection neurons
(type I), and its depletion is a sensitive marker of chronic ischemic
stress (Leifer and Kowall, 1993; Voelker et al., 2004), but SMI32(þ)
neurons have also been reported in AD and dementia with LewyTable 1
Demographic details of patients with CADASIL and controls
Group(n) Age (yr) Sex Mutation
CAD1 44 F Arg153Cys
CAD2 53 F Arg133Cys
CAD3 55 M Arg558Cys
CAD4 58 M Arg985Cys
CAD5 59 M Arg169Cys
CAD6 61 M Arg169Cys
CAD7 66 F D239_D253del
CAD8 68 F Arg133Cys
CAD9 68 M Arg153Cys
CAD10 63 M Arg141Cys
CAD11 65 M Arg141Cys
CAD12 52 M Arg141Cys
CADASIL group (mean) (12) 59 8M/4F 75% mutations in ex
Young controls (10) 54 3M/7F -
Older controls (7) 79 3M/4F -
Mean age (y) is shown for CADASIL (CAD), similar age of young controls and older cont
CADASIL and control participants (p > 0.05). In most patients with CADASIL, there was a
Key: CADASIL, cerebral autosomal dominant arteriopathy with subcortical infarcts and l
a Mild VCI and severe dementia or VaD were defined as per VICCCS criteria (Skrobot ebody (Thangavel et al., 2009). Although SMI32 abundantly exists in
neuronal cell bodies and dendrites, it is absent in normal myelin-
ated axons unless they are damaged and dysmyelinated (Trapp
et al., 1988). SMI32 staining, which appears as continuous lines,
small dots, or ovoids (retraction bulbs), is detected in axons only
after a longer dysmyelination periods, and thus, it is a useful indi-
cator of chronic axonal damage and possibly axonal degeneration
(Lindner et al., 2009).
2. Materials and methods
2.1. Subjects and cases
Table 1 provides the demographic details of each group used to
quantify vascular pathology, neuronal densities, and volumes in
CADASIL (n ¼ 12), young controls (n ¼ 10), and older controls (n ¼
7). Brain tissue was obtained from 4 resources: the Newcastle Brain
Tissue Resource, Newcastle General Hospital; MRC London Brain
Bank for Neurodegenerative Diseases; the MRC Sudden Death Brain
and Tissue Bank (Millar et al., 2007), the University of Edinburgh;
and the University Hospital at LMU Munich, Germany. CADASIL
diagnosis was confirmed based on the presence of NOTCH3 gene
mutations and associated clinical features. All patients with
CADASIL were cognitively impaired at death. Review of available
notes on patients with CADASIL indicated that they at least met the
mild VCI classification (Skrobot et al., 2018) Use of brain tissue was
approved by the local research ethics committee of the Newcastle
upon Tyne Hospitals NHS Foundation Trust, the Newcastle Brain
Tissue Resource committee, and the ethics committees overseeing
the brain banks at the other respective sites.
2.2. Histopathology and vascular pathology scores
As previous imaging studies had suggested changes in the
medial temporal lobe are associated with some memory deficits in
patients with CADASIL, we concentrated on the hippocampal for-
mation (Table 2). All the brain tissues were collected from the other
centers and analyzed in Newcastle, preventing any sampling bias or
introducing variation in the analysis. Temporal lobe blocks at theDuration (yr) Notable clinical features and risk factorsa
8 Cardiac arrhythmias; mild VCI
6 No vascular risk; mild VCI
11 Brief history of gout; mild VCI
13 No vascular risk; severe VCI or dementia
12 No vascular risk; severe VCI or dementia
10 Obesity (~55 y); severe VCI or dementia
23 No vascular risk, obesity; severe VCI or
dementia
18 Smoking history; severe VCI or dementia
28 Smoking, prostate tumor; severe VCI or
dementia
10 Enlarged thyroid; no vascular risk; mild VCI
13 Parenchymatous goiter; no vascular risk; mild
VCI
10 No vascular risk; severe VCI or dementia
on 4 12 Predominant characteristics of CADASIL
syndrome, majority with no vascular risk
factors
- No cerebrovascular or neurodegenerative
disorders-
rols. There were no statistical differences in mean ages between the patients with
cystine (Cys) replacement.
eukoencephalopathy; VaD, vascular dementia; VCI, vascular cognitive impairment.
t al., 2018) from available case notes.
Table 2
Spectrum of hippocampal pathology in CADASIL casesa
Group(n) Mutation Vascular path scoresa Arteriolosclerosis (0e3) PVS (0e3) Microinfarcts Y/N CA1 atrophy (0e3) Other features
CAD1 Arg153Cys 6 1 1 N 0 Normal size of
hippocampi
CAD2 Arg133Cys 8 2 1 N 1 Gliosis
CAD3 Arg558Cys 10 2 2 Y 2 Gliosis
CAD4 Arg985Cys 7 2 2 N 1 Gliosis
CAD5 Arg169Cys 8 3 2 N 1 Gliosis; relatively
preserved
CAD6 Arg169Cys 6 3 3 Y 2 b,eIntimal thickening in
vessels
CAD7 D239_D253del 9 3 2 Y 2 Gliosis; some vessels
with thrombotic
changes
CAD8 Arg133Cys 7 3 3 Y 2 b cArteriosclerotic
thickening
CAD9 Arg153Cys 9 3 3 Y 2 Arteriosclerotic
thickening
CAD10 Arg141Cys 7 2 2 Y 2 e Arteriosclerotic
thickening
CAD11 Arg141Cys 8 2 2 Y 2 e Arteriosclerotic
thickening
CAD12 Arg141Cys 8 3 3 Y 3 e Arteriosclerotic
thickening




Ycont (10)d - 3 1 N N 0 No cerebrovascular or
neurodegenerative
disorders
Ocont (7)d - 5.5 1 N N 1
Data show extent of hippocampal pathology (scores of 0e3; 0 ¼ none, 1 ¼ mild, 2 ¼ moderate, 3 ¼ severe).
Key: CADASIL, cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy; PVS, periventricular space.
a Scores were calculated as previously described (Deramecourt et al., 2012) out of 10 and the VCING Criteria (Skrobot et al., 2016).
b Evidence of hemosiderin.
c Diffuse amyloid-b plaques were found.
d Braak staging in CADASIL cases and controls were in range 0eII, except 81-year-old control (Supplementary Table S1). In addition, the overall ABC scores were determined
to be none to low for the CADASIL cases and all controls (Montine et al., 2012).
e Evidence of general atheromatous disease and occlusion in regions of the cerebrum other than the hippocampal formation of these cases.
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assessment of neuronal density. Cerebrovascular lesions including
SVD pathology were assessed as described previously
(Deramecourt et al., 2012). Sclerotic index was determined as
described previously (Craggs et al., 2012). Axonal changes in the
stem of the temporal lobe or temporal stem were assessed at the
level of the anterior hippocampus in adjacent sections used to
determine neuronal densities (Fig. 1). For neuronal counts and
volumes, formalin-fixed, paraffin-embedded blocks were serially
sectioned at thicknesses of 30 mm. They were immunostained usingFig. 1. (A) Diagram of the coronal block from one hemisphere of the cerebrum at the level of
a 79-year-old control participant at the level of the hippocampal formation taken for neur
pocampal formation. (A, B) Boxes show delineated sample areas and (C) shows the anatom
ammonis (CA1 and CA2), which were assessed for pathological quantification. Abbreviationmouse antienonphosphorylated neurofilament H (anti-SMI32,
Covance, CA; 1:500) monoclonal antibody to identify large pyra-
midal neurons and damaged axons in the white matter (WM)
(Lindner et al., 2009; Voelker et al., 2004) and then counterstained
with 0.1% cresyl fast violet to reveal the total neuron population.
To assess neurodegenerative pathology, sections were stained
with hematoxylin and eosin for structural integrity and infarcts,
Nissl and Luxol fast blue staining for cellular patterns and myelin
loss, and Bielschowsky's silver impregnation and Gallyas stain for
neuritic pathology. Amyloid-b and tau immunohistochemistrythe anterior hippocampal formation; (B) Coronal fixed tissue slice from the cerebrum of
opathological examination; (C) Section stained with Nissl showing the complete hip-
ical regions of the temporal stem (TS), the entorhinal cortex layer V (ECV), and cornu
s: DG, dentate gyrus; SB, subiculum.
Fig. 2. The image shows how 3-dimensional stereology was used to quantify neuronal
numbers and volumes. Neurons with nucleolus within counting frame or touching
green lines were measured. The middle 15-mm depth was scanned through to identify
neurons and glial cells within the dissector box. Glial cells and neurons with a
nucleolus inside or touching the green lines were counted and measured for volume
estimation. Neurons were marked with N, SMI32-positive neurons (colored brown)
with S, and glial cells with G. The intersections of lines with cell membrane were
marked by the researcher for volume estimation.
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neurofibrillary tangles and rate ABC for amyloid b deposits (A),
staging of neurofibrillary tangles (B), and scoring of neuritic plaques
(C) scores as per National Institute on AgingeAlzheimer's Associa-
tion guidelines (Table 2). Unless otherwise stated, all the tissues
were processed for fixation in 10% buffered formalin and embedded
in paraffin following standard protocols established in clinical his-
topathology services.
2.3. Unbiased 3-dimensional stereological quantification
Three-dimensional stereological quantification of cell density
and volume was determined essentially as described previously
(Gemmell et al., 2012, 2014). We also ensured sections from the
hippocampal formation from both CADASIL and controls were free
of any direct tissue damage due to infarction. Thus, purely effects of
remote ischemic injury were evaluated on the hippocampal for-
mation. Briefly, 2 randomly selected 30-mm sections per sample
were analyzed using a Visiopharm Integrator System (Visiopharm,
Denmark). The precise regions of interest (ROI) in the EC (layer V,
ECV) and hippocampus (cornu ammonis, CA1 and CA2; Fig. 1) were
defined as previously described (Amaral and Insausti, 1990). Cell
counts and volume estimations were conducted using a 100x oil-
immersion objective on a Zeiss Axioplan Photomicroscope,
whereas the XY and Z motorized stage (Prior ProScan II, Prior Sci-
entific Instruments Ltd, UK) provided systematic random sampling.
The unbiased dissector and nucleator method were used to esti-
mate density and size of neurons and glial cells (Fig. 2). Tissue
section thickness was measured using a Heidenhain gauge (Hei-
denhain GB Ltd, UK) at every 10th field during analysis. Approxi-
mately 40e80 fields per ROI were analyzed to achieve an identical
sampling fraction for each ROI. Neurons were counted only when
their nucleoli could be identified, and the cell body was either fully
inside the dissector box measuring 56.43  45.14 mm or touching 1
of the 3 nonforbidden planes (right, top, and upper side) within the
dissector height, which was set at 15 mm. SMI32-positive neurons
were counted separately from the total neuron population.
2.4. SMI32-positive axons
Previous studies have shown that chronically damaged axons
show accumulation of nonphosphorylated neurofilaments H which
is revealed with SMI32 immunoreactivity (Lindner et al., 2009). Asdescribed previously (Craggs et al., 2014), SMI32-stained sections
from CADASIL and young and older controls were viewed under an
Olympus BX51 upright microscope coupled with an mbf Bioscience
CX9000 camera and analyzed with a Stereo Investigator (MBF
Bioscience, VT, USA) using the Space Balls probe. SMI32 axons were
examined in the whole temporal stem WM region as the ROI
(Fig. 1).
2.5. Statistical analyses
Comparisons between CADASIL, young control, and old control
participants were made using Kruskal-Wallis and Mann-Whitney U
tests incorporated in SPSS, version 17.0. Correlations between a
number of variables including neuronal densities as actual values,
SMI32 positive and negative stained axonal densities determined as
percent area, and MMSE scores were tested using Spearman's rank
order correlation.
3. Results
3.1. Neuronal and vascular pathology in the hippocampal formation
Routine neuropathological examination of sections from the
medial temporal lobe of CADASIL cases was unremarkable. They did
not show marked atrophy compared with those from young or
older controls. Hippocampi were largely of the expected size
(Table 2). We noted mild to moderate hippocampal sclerosis in CA1
region in CADASIL cases. Immunostaining with antibodies to
pathological markers of AD confirmed the general absence of any
significant pathology or neurofibrillary tangle burden both in
CADASIL cases and all controls (Table 2; Supplementary Table S1),
where available Braak staging for neurofibrillary tangles was
recorded to be in range 0eII in all but one old control participant,
who exhibited Braak stage III. The overall ABC scoring for AD type of
pathology was also determined to be none to low in the CADASIL
cases and controls (Montine et al., 2012).
To determine if neuronal status was influenced by vascular le-
sions or infarctions in the hippocampal formation of patients with
CADASIL, we also determined several features of microvascular
pathology. We found that the mean vascular pathology scores
incorporating cortical and subcortical areas (Deramecourt et al.,
2012) in patients with CADASIL were greater than those in older
controls (Table 2). Although we noted variable arteriopathy with a
median score of 2, except for a couple of cases, microvascular pa-
thology in the hippocampal formation was not remarkable in
CADASIL. There were no obvious small or large infarcts in any of the
cases or controls. We found that the sclerotic index of hippocampal
in relation tomedial temporal lobe vessels in patients with CADASIL
was significantly greater than that in young controls (0.43 vs. 0.30, p
< 0.001). We found no clear relationship between hippocampal
neuronal or microvascular pathology and any particular NOTCH3
genotype. However, the most severe vascular pathology was pre-
sent in the participant with a NOTCH3 mutation in exon 11. Overall,
the lack of infarctions or any neuronal sclerosis in CA1 region of the
hippocampal formation could not explain the selective neuronal
changes we observed (Fig. 3).
3.2. Pyramidal neuronal densities and volumes
Relative to total neurons detected with conventional tinctorial
staining, we had a particular interest in the status of SMI32-positive
neurons. We first noted that proportional densities of SMI32-
positive neurons to total neurons in young control participants
were44.5% in theECV, 45.4% inCA1, and75.9% inCA2 regions (Fig. 3).
InpatientswithCADASIL, percentage of SMI32-positive neuronswas
Fig. 3. Neuron densities in patients with CADASIL and control participants. Differences in SMI32-positive and total cell densities in patients with CADASIL in the entorhinal cortex,
layer V (ECV) and hippocampus regions CA1 and CA2 relative to young and older controls. SMI32-positive neuronal density was decreased in CADASIL and older controls (B). *:
Significance (p < 0.05) and þ: trend (p < 0.1) versus age-matched controls or between controls. Error bars  2SE. Abbreviations: CADASIL, cerebral autosomal dominant arte-
riopathy with subcortical infarcts and leukoencephalopathy.
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regions (p ¼ 0.008 and p ¼ 0.037), respectively. There were also
fewer SMI32-positive neurons in the CA1, but these were not
significantly different from young control participants at the 5%
significance level. Comparedwith the young controls, we also found
SMI32-positive neurons to be lower in old control participants, but
differences in mean densities and percentage of SMI32-positive
neurons were significant only in the CA1 (p ¼ 0.019 and p ¼ 0.037)
and only trend was observed in ECV (p ¼ 0.075 and p ¼ 0.094).
After these observations, correlation analysis between SMI32-
positive and -negative neuron densities was performed to deter-
minewhether the observed decrease in the SMI32-positive neurons
in old control participants and patients with CADASIL was a true
indication of large pyramidal neuronal loss or merely reflecting loss
of SMI32 immunoreactivity. As expected, controls showed corre-
lation between SMI32-positive and SMI32-negative neuronalFig. 4. Axonal abnormalities in the temporal stem of patients with CADASIL. Examples of m
axonal changes in the temporal stem WM of (A, D), young controls; (B, E), older controls; a
were evident in CADASIL (inset in F). Bar ¼ 100 mm. Abbreviations: CADASIL, cerebral autos
white matter.density (young and old controls combined; CA1: R ¼ 0.471, p ¼
0.076; CA2: R ¼ 0.675, p ¼ 0.006). However, there was no sig-
nificant correlation in any of the regions in CADASIL cases. These
results indicated that while only the expression of SMI32 was
reduced in older controls, small numbers of large pyramidal neu-
rons were lost in the hippocampus of CADASIL (coincident with
decreased SMI32 expression).
We found the ECV and CA2 regions had the largest estimates of
neurons in range 70,000e80,000 per mm3. In contrast to SMI32-
positive neurons, total neuronal densities were relatively pre-
served in the in the ECV and CA1 regions in CADASIL comparedwith
young control and old control groups but tended to be reduced in
the CA2 region (p ¼ 0.071, Kruskal-Wallis test) (Fig. 3B).
The mean volumes of neurons in young control in the ECV, CA1,
and CA2 regions were 1788 mm3, 2303 mm3, and 2765 mm3,
respectively. There were no detectable differences in neuronalyelin (LFB) staining and SMI32 immunostaining show severity of demyelination and
nd (C, F) patients with CADASIL. Highly contrasting SMI32-immunostained structures
omal dominant arteriopathy with subcortical infarcts and leukoencephalopathy; WM,
Y. Yamamoto et al. / Neurobiology of Aging 97 (2021) 33e4038volumes between CADASIL and young control participants or be-
tween young control and old control groups (p > 0.05).
The density of glial cell was similar between groups in any of the
regions (p > 0.05). A difference was only found in the glial cell
number per neuron between young and old controls (p ¼ 0.042) in
CA1, although it may be the result of the decreased neurons and
retained glial populations.
3.3. Axons in the temporal stem
Consistent with our previous report (Craggs et al., 2014), we
found intense and abundant SMI32 staining in the temporal stem
WM of patients with CADASIL compared with all controls (Fig. 4).
Varying degrees of SMI32-positive axonal degeneration, such as
fragments of axons, swollen segments, and ‘retraction bulbs,’ were
evident in the temporal stem of all CADASIL cases, whereas not in
young controls. There was a general absence of SMI32-positive
changes in control samples in contrast to the CADASIL samples.
We did not undertake further quantitative analyses of this more
narrowed ROI given the length density of SMI32-positive axons was
doubled in patients with CADASIL compared with young controls as
reported previously (Craggs et al., 2014).
4. Discussion
Our study provides the first quantitative data on selective
neuronal changes underlying cognitive dysfunction, specifically in
the medial temporal lobeerelated memory deficits in CADASIL. Our
observations are substantiated by the fact that densities of hippo-
campal neurons and damaged axons were quantified using current
state-of-the-art unbiased stereological techniques. Although the
total neuronal densities in the hippocampal formation of patients
with CADASIL were relatively preserved, there were marked losses
of ~26%e50% in SMI32-positive neurons in the ECV and CA2 re-
gions. Another remarkable observation was the differential loss of
neuronal densities with age in that the older control group had
fewer total neurons than young controls in the ECV. Specific losses
in pyramidal neurons of the ECV are particularly of note because
this region has been implicated in early phases of neurodegenera-
tive disorders such as AD. It has been suggested that thread-like
neuronal processes and tau neurites develop first in layer II and
then spread via axons to layer V of the EC. Losses in SMI32 neurons
in both the ECV and CA2 can only be explained by a vascular eti-
ology rather than any protein inclusions and propagation or
transmission as suggested to take place in AD (Braak and Del
Tredici, 2015; Gibbons et al., 2019; Goedert et al., 2017). The ECV
receives inputs intrinsically from EC layers II and III, which connect
the CA regions of the hippocampus via the performant pathway and
the CA1 region then closes the loop with medial and lateral pro-
jections to the ECV via the subiculumwith a subsequent outflow to
the thalamus and isocortical regions (Knierim, 2015; Ohara et al.,
2018). Any memory deficits associated with CADASIL likely result
from the weakening of this intrinsic hippocampal-entorhinal cir-
cuitry. It should be emphasized that these specific neuronal
changes occur in the general absence of any type of Alzheimer
pathology either in the EC or hippocampus proper and are purely
driven by processes associated with SVD.
We have previously shown that the CA1 region of the hippo-
campus is particularly vulnerable, irrespective of the presence of AD
type of pathology in poststroke survivors who develop VCI or de-
mentia (Gemmell et al., 2012, 2014). We previously suggested there
is a strong vascular basis of neuronal density and volume reductions
in the CA1 and CA2 regions, respectively. CADASIL is characterized
by executive dysfunction with relatively preserved hippocampal
functions (e.g., episodic memory) until progression into late stages(Buffon et al., 2006; O'Sullivan et al., 2009). The lack of total
neuronal density changes in the hippocampus of patients with
CADASIL suggests there is less extensive involvement of the entire
hippocampal structure even though these patients are clinically
impaired and develop VCI.
Previous studies have shown that SMI32 immunoreactivity is
depleted after cerebral ischemia, especially in chronic lesions
(Leifer and Kowall, 1993). Our observations suggest that patients
with CADASIL likely experienced chronic ischemic stress causing
almost similar loss of SMI32-positive neurons in hippocampus and
EC as in older controls. A few studies reported neuronal hypertro-
phy in AD and mild cognitive impairment, implying that it is
involved in their pathology (Iacono et al., 2008). However, there
were no significant differences in neuronal volumes although
neuronal volumes in CA2 regions tended to be greater compared
with younger controls. Our results are supported by the observa-
tions of Viswanathan et al. (2006) and Mesulam et al. (Mesulam
et al., 2003), which noted lack of significant changes in apoptotic
neuron number and cholinergic denervation, respectively, in the
hippocampus of patients with CADASIL.We further investigated the
profile of mild neuronal loss in the hippocampal formation and
found selective vulnerability of SMI32-positive neurons. SMI32, a
200 kDa nonphosphorylated neurofilament, is expressed in large
pyramidal projecting neurons, which are most abundantly found in
the long association pathway connecting frontal, temporal, and
parietal cortices (Hof et al., 1995). Our results not only confirm the
previously reported vulnerability of these pyramidal neurons to
ischemic stress (Leifer and Kowall, 1993; Thangavel et al., 2008,
2009) but also suggest that WM disconnection precedes neuronal
loss in CADASIL. It is not unlikely that microstructural damage in
WM tracts connecting infarcted regions with distant cortex causes
secondary cortical neurodegeneration as a mechanism for brain
atrophy (Duering et al., 2012, 2015). It is also plausible that the SVD
type of changes in subcortical structures cause a chronic hypoxic
state (Fernando et al., 2006; O'Sullivan et al., 2005), which makes
the WM more vulnerable with increasing age (Ihara et al., 2010).
We also found profound abnormal SMI32 accumulation in the
temporal stemWM of patients with CADASIL. This suggests chronic
axonal damage (Lindner et al., 2009) secondary to the widespread
demyelination in subcortical WM in CADASIL. The stem of the
temporal lobe (temporal stem) forms a bridge between the tem-
poral lobe and other regions of the brain and is traversed by the
uncinate fasciculus, inferior occipitofrontal fasciculus, and Meyer's
loop of the optic radiation (Kier et al., 2004). The uncinate fasciculus
is a monosynaptic corticocortical route of interaction between the
temporal and frontal lobes. Reduction in volume or axonal abnor-
malities of the temporal stem would affect both efferent and
afferent WM tracts as they enter and exit the temporal lobe.
Increased water diffusion likely results from disruption and loss of
axonal membranes andmyelin stem that has also been described in
patients with AD (Hanyu et al., 1998).
The disconnection syndrome is a theory that brain dysfunction
can be, at least in part, attributed to disrupted associative connec-
tions between various brain regions by WM abnormality (Catani
and Ffytche, 2005). In AD, for example, the functional anterior-
posterior disconnection and changes in medial temporal struc-
tures were associated with delayed memory (Grady et al., 2001).
Patients with CADASIL exhibit rather specific spatial distribution of
WM lesions as shown by magnetic resonance imaging (Coulthard
et al., 2000) and our previous clinicopathological studies (Craggs
et al., 2014). Prior studies had further shown that NOTCH3 muta-
tion carriers display WM abnormalities early in the disease that is
detectable well before the occurrence of stroke, cognitive impair-
ment, and disability (Chabriat et al., 1998). Consistent with this,
neuronal apoptosismay contribute to cortical atrophy and cognitive
Y. Yamamoto et al. / Neurobiology of Aging 97 (2021) 33e40 39impairment in patients with CADASIL and that may result from
axonal damage in the underlying WM (Gray et al., 2007). Moreover,
experimental studies in Notch3R169C mice suggest that segmental
intramyelinic edema is an early conspicuous WM change in
CADASIL (Cognat et al., 2014). Thus, it is plausible that disrupted
frontal lobe connectivity with the temporal lobe underlies the
cognitive deficits in CADASIL. Notwithstanding, Tatsch et al. (2003)
considered disconnections by subcortical lesions as one of the
causes of reduced cortical metabolism and cognitive dysfunction in
CADASIL.
We used CADASIL brain tissues from several different resources,
which inevitably could result in the inconsistency in diagnostic
criteria, neuroimaging methods, and neuropsychological tests. The
limitations of the present study included the lack of a full spectrum
of neuropsychometric scores and quantitative magnetic resonance
imaging data for all CADASIL cases, which prevented us from
properly relating the pathological changes to temporal lobe neu-
roimaging and cognitive function data. Establishing large prospec-
tive studies of patients with CADASIL by collaborating centers
would facilitate studies into the etiology of medial temporal lobe
atrophy in neurodegenerative diseases such as AD and CADASIL as a
model of sporadic SVD leading to dementia.
5. Conclusions
Our results show selective loss of neurons in the hippocampal
formation, suggesting this is a proxy for the observed hippocampal
volume loss in CADASIL as demonstrated by previous neuroimaging
studies (O'Sullivan et al., 2009). Our results also suggest that WM
integrity in the temporal stem is compromised and is a factor in the
observed cell loss in the hippocampal formation, particularly in the
ECV. These observations collectively may explain the cognitive
dysfunction associated with the temporal lobe in CADASIL. In future
investigations, it is imperative to evaluate neuronal densities in
other areas of the temporal lobe similar to the frontal lobes
(Bussière et al., 2003; Foster et al., 2014; Hof et al., 1990).
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